453 related articles for article (PubMed ID: 24070847)
21. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China.
Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC
Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420
[TBL] [Abstract][Full Text] [Related]
22. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
MacCallum DM; Coste A; Ischer F; Jacobsen MD; Odds FC; Sanglard D
Antimicrob Agents Chemother; 2010 Apr; 54(4):1476-83. PubMed ID: 20086148
[TBL] [Abstract][Full Text] [Related]
23. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.
Strzelczyk JK; Slemp-Migiel A; Rother M; Gołąbek K; Wiczkowski A
Acta Biochim Pol; 2013; 60(4):547-52. PubMed ID: 24340302
[TBL] [Abstract][Full Text] [Related]
24. Principles of a New Protocol for Prediction of Azole Resistance in Candida albicans Infections on the Basis of ERG11 Polymorphisms.
Caban M; Strapagiel D; Dziadek J; Korycka-Machała M; Grzelak A
Curr Microbiol; 2016 Aug; 73(2):172-82. PubMed ID: 27107760
[TBL] [Abstract][Full Text] [Related]
25. Loss of C-5 Sterol Desaturase Activity in
Luna-Tapia A; Butts A; Palmer GE
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323044
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China.
Jiang C; Dong D; Yu B; Cai G; Wang X; Ji Y; Peng Y
J Antimicrob Chemother; 2013 Apr; 68(4):778-85. PubMed ID: 23221625
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ
Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
[TBL] [Abstract][Full Text] [Related]
29. Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene.
Feng LJ; Wan Z; Wang XH; Li RY; Liu W
Chin Med J (Engl); 2010 Mar; 123(5):544-8. PubMed ID: 20367978
[TBL] [Abstract][Full Text] [Related]
30. A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.
Martel CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2010 Sep; 54(9):3578-83. PubMed ID: 20547793
[TBL] [Abstract][Full Text] [Related]
31. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
[TBL] [Abstract][Full Text] [Related]
32. First detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou/Burkina Faso.
Dovo EE; Zohoncon TM; Tovo SF; Soubeiga ST; Kiendrebeogo IT; Yonli AT; Ouedraogo RA; Dabire AM; Djigma FW; Nadembega CW; Belemgnegre M; Ouedraogo P; Obiri-Yeboah D; Simpore J
BMC Infect Dis; 2022 Aug; 22(1):678. PubMed ID: 35941587
[TBL] [Abstract][Full Text] [Related]
33. Molecular differentiation and antifungal susceptibility of Candida albicans isolated from patients with respiratory infections in Guiyang Medical College Hospital, China.
Liu Y; Kang Y; Yokoyama K; Gonoi T; Mikami Y
Nihon Ishinkin Gakkai Zasshi; 2009; 50(3):175-8. PubMed ID: 19654451
[TBL] [Abstract][Full Text] [Related]
34. Detection of ERG11 Overexpression in Candida albicans isolates from environmental sources and clinical isolates treated with inhibitory and subinhibitory concentrations of fluconazole.
Morais Vasconcelos Oliveira J; Conceição Oliver J; Latércia Tranches Dias A; Barbosa Padovan AC; Siqueira Caixeta E; Caixeta Franco Ariosa M
Mycoses; 2021 Feb; 64(2):220-227. PubMed ID: 33176021
[TBL] [Abstract][Full Text] [Related]
35. [Azole resistance in Candida albicans].
Perea S
Rev Esp Quimioter; 2000 Sep; 13(3):314-7. PubMed ID: 11086283
[TBL] [Abstract][Full Text] [Related]
36. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.
Wang H; Kong F; Sorrell TC; Wang B; McNicholas P; Pantarat N; Ellis D; Xiao M; Widmer F; Chen SC
BMC Microbiol; 2009 Aug; 9():167. PubMed ID: 19682357
[TBL] [Abstract][Full Text] [Related]
37. In vitro fluconazole susceptibility of 1,903 clinical isolates of Candida albicans and the identification of ERG11 mutations.
Ying Y; Zhao Y; Hu X; Cai Z; Liu X; Jin G; Zhang J; Zhang J; Liu J; Huang X
Microb Drug Resist; 2013 Aug; 19(4):266-73. PubMed ID: 23484590
[TBL] [Abstract][Full Text] [Related]
38. An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans.
Hoot SJ; Smith AR; Brown RP; White TC
Antimicrob Agents Chemother; 2011 Feb; 55(2):940-2. PubMed ID: 21078937
[TBL] [Abstract][Full Text] [Related]
39. Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.
Nishimoto AT; Sharma C; Rogers PD
J Antimicrob Chemother; 2020 Feb; 75(2):257-270. PubMed ID: 31603213
[TBL] [Abstract][Full Text] [Related]
40. Loss of Upc2p-Inducible
Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
mBio; 2018 May; 9(3):. PubMed ID: 29789366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
